FDA clears modification for XACT's ablation steering system

By AuntMinnie.com staff writers

May 18, 2022 -- The U.S. Food and Drug Administration (FDA) has cleared a modification for XACT's Ace Robotic system.

Ace combines image-based procedure planning and real-time monitoring with hands-free robotic insertion and nonlinear steering. The new FDA clearance now includes robotic insertion and steering of ablation probes during ablation procedures, and it features a 1.7-mm tip for high insertion accuracy, according to XACT.

The company plans to highlight Ace at the upcoming Society of Interventional Radiology meeting in Boston.

Copyright © 2022 AuntMinnie.com

To read this and get access to all of the exclusive content on AuntMinnie.com create a free account or sign-in now.

Member Sign In:
MemberID or Email Address:  
Do you have a AuntMinnie.com password?
No, I want a free membership.
Yes, I have a password:  
Forgot your password?
Sign in using your social networking account:
Sign in using your social networking